If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEden Regulatory News (EDEN)

Share Price Information for Eden (EDEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.30
Bid: 4.10
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.40 (9.756%)
Open: 4.30
High: 4.30
Low: 4.30
Prev. Close: 4.30
EDEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Licence Agreement with SUMIAGRO

1 Dec 2014 07:00

RNS Number : 3789Y
Eden Research plc
01 December 2014
 



Eden Research Plc

("Eden" or "Company")

 

Exclusive Licence Agreement with SUMIAGRO France SAS for grape protection products

 

Eden Research plc (AIM: EDEN), the AIM listed natural micro-encapsulation company, announces that it has signed an exclusive Licence Agreement with Sumi Agro France SAS ("Sumi Agro") to sell 3AEY, an Eden-developed plant protection product in France. In addition, Sumi Agro will have the right to trial, register, develop and sell certain other plant protection products for use in France using Eden's natural encapsulation technology, GO-E Inside™.

 

The Licence Agreement, which lasts for 20 years, covers the use of 3AEY in a number of agricultural applications and the initial targeted use will be on grapes for control of Botrytis, a fungus that affects many plants and is a major concern across Europe.

 

This follows the news announced on 21 November 2014 that Eden signed an exclusive Licence Agreement with Sipcam Italia Spa and Sipcam Iberia to sell 3AEY in Italy and Spain, respectively. 

 

Under the terms of the agreement, Eden will receive an upfront payment followed by a number of milestone payments relating to the approval of the product by the EU, which is expected in spring 2015, and sales targets. Eden will also receive ongoing royalty payments based on product sales. 

 

Sean Smith, Chief Executive Officer of Eden, said: "France is a well-known grape growing country where the market for Botryticides is, historically, the largest in the world. Ensuring that we have the right partner which is able to fully exploit the opportunities for effective products such as 3AEY in this market is, therefore, critical. We strongly believe that SUMIAGRO France is that partner and expect that Eden will benefit greatly from the weight that their name and expertise carries in France.

 

Beyond this agreement and 3AEY, we look forward to developing other product opportunities with Sumi Agro France as well as with affiliated Sumitomo Corporation companies. "

 

Antoine Meyer, President of Sumi Agro, said: "We fully recognize that, with 3AEY, Eden's technology is clearly an innovative BioControl answer to vineyard growers looking to satisfy their workers' concerns and consumers' demand: 3AEY botryticide provides distributors and growers with a new tool adapted to modern and increasingly sustainable farming.

 

This agreement expresses our Sumi Agro commitment to invest in modern crop protection solutions based on conventional as well as BioControl tools."

 

Eden Research plc

www.edenresearch.com

Sean Smith, Chief Executive Officer

Tel: 01993 862 761

Alex Abrey, Chief Financial Officer

W H Ireland Limited

Tel: 0117 945 3471

John Wakefield / Ed Allsopp

Walbrook PR Ltd

Tel: 020 7933 8780 or eden@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

Notes:

 

Eden is an early stage revenue company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions to the global agrochemicals industry, the animal health industry, and consumer products.

 

Eden's encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic hydrophobic compounds. The technology uses yeast cells that are a by-product of numerous commercial production processes to deliver a slow release of natural compounds for agricultural and non-agricultural uses. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries.

 

Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.

 

With leading consultants in their respective fields, the Company is developing these technologies through innovative research and a series of commercial production, marketing and distribution partnerships.

 

The Company has a number of patents and a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. To date, the Company has invested in the region of £12m in developing and protecting its intellectual property and seeking regulatory approval for products that rely upon the Company's technologies. Revenues earned by the Company have been modest whilst the Company has concentrated on securing patent protection for its intellectual property, gaining regulatory approvals, identifying suitable industrial partners, and entering into licence agreements.

 

In May of 2013, the three actives that comprise Eden's first commercial product, 3AEY, were approved as new ingredients for use in plant protection products. This represents a major milestone in the commercialisation of Eden's technology and is a significant accomplishment for any company. To illustrate this point, one should note that in all of 2013, Eden's approvals represented 3 of only 10 new active ingredients approved by the EC.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN.

 

For more information about Eden, please visit www.edenresearch.com

 

 

 

Sumi Agro France is a European affiliated company of the Japanese SUMITOMO CORPORATION group, one of the largest trading house in the World. In 2012, Sumi Agro and Sipcam signed an alliance, creating a common platform for the development, marketing and distribution of products for Agriculture, covering all European markets.

 

Thanks to its closed relationship with numerous corporations, not only in Asia, but everywhere in the World, Sumi Agro has a continuous access to new active ingredients and technologies.

 

Sumi Agro built solutions for an efficient crop protection, economically relevant and consistent with a Sustainable Agriculture, respecting the Environment and able to supply quality food for all.

 

Sumi Agro is a member of ECPA / UIPP and IBMA associations.

For more information about SUMI AGRO, please visit www.sumiagro.fr - www.sumiagro.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRPGGMWGUPCGQR
Date   Source Headline
9th May 20247:00 amRNSInvestor Presentation via Investor Meet Company
7th May 20247:01 amRNSAppointment of Non-Executive Director
7th May 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
31st Jan 20247:00 amRNSBoard Change
22nd Jan 20247:00 amRNSTrading Update
19th Jan 20243:00 pmRNSHolding(s) in Company
9th Jan 20247:01 amRNSMevalone Approval in the State of California
18th Dec 20237:00 amRNSEcovelexâ„¢2023 Approval in Italy
28th Nov 20237:00 amRNSSmall Cap Virtual Investor Conference
1st Nov 20237:00 amRNSChange of Nominated Adviser and Broker
9th Oct 20234:44 pmRNSHolding(s) in Company
9th Oct 20234:39 pmRNSHolding(s) in Company
9th Oct 202312:46 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSCompletion of Conditional Placing
29th Sep 20237:01 amRNSHalf Yearly Report
29th Sep 20237:00 amRNSCapital Raising Update
31st Aug 20236:25 pmRNSGrant of Awards under Long-Term Incentive Plan
17th Aug 20239:27 amRNSResult of GM and Capital Raising update
16th Aug 20237:00 amRNSFirst Order For Ecovelex
2nd Aug 20233:22 pmRNSResult of Retail Offer
28th Jul 20235:00 pmRNSRetail Offer
28th Jul 20235:00 pmRNSPlacing and Retail Offer
3rd Jul 20237:00 amRNSRegulatory Application for Ecovelex in the UK
30th Jun 20239:17 amRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
15th Jun 20237:00 amRNSAppointment of New Product Distributor – Colombia
9th Jun 20234:29 pmRNSHolding(s) in Company
7th Jun 20237:00 amRNSPublication of Annual Report and Notice of AGM
5th Jun 20234:47 pmRNSHolding(s) in Company
30th May 20237:00 amRNSEden and Corteva seek to bring Ecovelex to market
17th May 20237:00 amRNSExercise of Options
15th May 20237:00 amRNSMevalone authorisation in New Zealand
12th May 20237:00 amRNSRegulatory approvals in California and Florida
5th May 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
17th Apr 20237:00 amRNSRegulatory authorisation for Mevalone in Poland
23rd Mar 20237:00 amRNSUS State Regulatory Approvals Update
30th Jan 20237:00 amRNSFirst Mevalone authorisation for domestic use
10th Jan 20237:00 amRNSTrading Update
15th Dec 20222:01 pmEQSEden Research signs new Mevalone distribution deal
15th Dec 20227:00 amRNSDistribution Agreement for Mevalone in France
30th Nov 20227:00 amRNSOrganic Certification in Greece
24th Oct 202212:00 pmRNSAIM Rule 17 Notification
3rd Oct 20224:39 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSEden Half Yearly Report
28th Sep 20228:46 amRNSAppointment of Auditor
27th Sep 20225:08 pmEQSEden granted US EPA regulatory approval
26th Sep 20227:00 amRNSEden granted US EPA regulatory approval
2nd Sep 20227:00 amRNSAppointment of Non-Executive Director
22nd Aug 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.